Stefan Galluppi, Chief Innovation Officer at LifeMD, Inc. (LFMD), sold 85,000 shares at $12.38 ($1.1M) on 2025-06-13, disclosed to the SEC on 2025-06-17.
Scheduled sale ($1.1M) by Chief Innovation Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| LFMD | BUY | 2023-05-23 | $22K | — | Filing → |
| LFMD | BUY | 2021-11-18 | $9K | — | Filing → |
| LFMD | BUY | 2021-11-16 | $10K | — | Filing → |